NCT04338620 2023-03-06
Camrelizumab Combined With Albumin-bound Paclitaxel and Platinum in Neoadjuvant Treatment of Resectable NSCLC
Tang-Du Hospital
Phase 2 Unknown
Tang-Du Hospital
Second Affiliated Hospital, School of Medicine, Zhejiang University
Sichuan Cancer Hospital and Research Institute
Peking Union Medical College
Gruppo Oncologico Italiano di Ricerca Clinica
First People's Hospital of Hangzhou
Tongji University